All Stories

  1. Association of OSA with Soluble Biomarkers of Lung and Vascular Injury: The Multi-Ethnic Study of Atherosclerosis

    Article • SLEEP, November 2024, Oxford University Press (OUP)

    David Lederer

  2. Development of the Lung Transplant Frailty Scale (LT-FS)

    Article • The Journal of Heart and Lung Transplantation, February 2023, Elsevier

    David Lederer

  3. Radiographic Lung Abnormalities in First-Degree Relatives of Patients With Different Subtypes of Pulmonary Fibrosis

    Article • CHEST Journal, January 2023, Elsevier

    David Lederer

  4. Selective serotonin reuptake inhibitors and lung function in the multi-ethnic study of atherosclerosis lung study

    Article • Respiratory Medicine, March 2022, Elsevier

    David Lederer

  5. Summary for Clinicians: Clinical Practice Guideline on Home Oxygen Therapy for Adults with Chronic Lung Disease

    Article • Annals of the American Thoracic Society, April 2021, American Thoracic Society

    David Lederer

  6. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline

    Article • American Review of Respiratory Disease, November 2020, American Thoracic Society

    David Lederer

  7. Deep Learning of CT Virtual Wedge Resection for Prediction of Histologic Usual Interstitial Pneumonitis

    Article • Annals of the American Thoracic Society, August 2020, American Thoracic Society

    David Lederer

  8. Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis

    Article • ERJ Open Research, January 2020, European Respiratory Society (ERS)

    David Lederer

  9. Donor surfactant protein A2 polymorphism and lung transplant survival

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    David Lederer

  10. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, November 2019, American Thoracic Society

    David Lederer

  11. Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study

    Article • Annals of the American Thoracic Society, November 2019, American Thoracic Society

    David Lederer

  12. Risk factors for disease progression in idiopathic pulmonary fibrosis

    Article • Thorax, October 2019, BMJ

    David Lederer

  13. Concomitant Medications and Clinical Outcomes in Idiopathic Pulmonary Fibrosis

    Article • European Respiratory Journal, September 2019, European Respiratory Society (ERS)

    David Lederer

  14. Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure

    Article • Thorax, September 2019, BMJ

    Dr. Matthew R Baldwin, David Lederer

  15. Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis

    Article • European Respiratory Journal, August 2019, European Respiratory Society (ERS)

    David Lederer

  16. Aryl-Hydrocarbon Receptor Repressor Gene in Primary Graft Dysfunction after Lung Transplantation

    Article • American Journal of Respiratory Cell and Molecular Biology, August 2019, American Thoracic Society

    David Lederer, Dr David J Lederer

  17. Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation

    Article • Annals of the American Thoracic Society, July 2019, American Thoracic Society

    David Lederer

  18. Cryobiopsy for Interstitial Lung Disease: The Heat Is On

    Article • American Review of Respiratory Disease, May 2019, American Thoracic Society

    David Lederer

  19. AnnalsATS: New Developments and Advice for Authors

    Article • Annals of the American Thoracic Society, May 2019, American Thoracic Society

    David Lederer

  20. The Annals of the American Thoracic Society Editorial Fellowship Program

    Article • Annals of the American Thoracic Society, April 2019, American Thoracic Society

    David Lederer

  21. More on Causal Inference Studies

    Article • Annals of the American Thoracic Society, February 2019, American Thoracic Society

    David Lederer

  22. Reply: Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?

    Article • Annals of the American Thoracic Society, February 2019, American Thoracic Society

    David Lederer

  23. Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study

    Article • Annals of the American Thoracic Society, February 2019, American Thoracic Society

    David Lederer

  24. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    Article • Annals of the American Thoracic Society, January 2019, American Thoracic Society

    David Lederer, Prof Nicholas Hart

  25. Reply

    Article • Arthritis & Rheumatology, December 2018, Wiley

    David Lederer

  26. 2018 Clinical Practice Guideline Summary For Practicing Clinicians: Diagnosis of Idiopathic Pulmonary Fibrosis

    Article • Annals of the American Thoracic Society, December 2018, American Thoracic Society

    David Lederer, Dr Thomas Bice

  27. Optimizing Home Oxygen Therapy. An Official American Thoracic Society Workshop Report

    Article • Annals of the American Thoracic Society, December 2018, American Thoracic Society

    David Lederer

  28. The Phillip Morris Foundation for a Smoke-Free World. A Cause for Concern

    Article • Annals of the American Thoracic Society, November 2018, American Thoracic Society

    David Lederer

  29. Bidirectional transfer of Anelloviridae lineages between graft and host during lung transplantation

    Article • Arabian archaeology and epigraphy, October 2018, Wiley

    David Lederer

  30. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    Article • American Review of Respiratory Disease, September 2018, American Thoracic Society

    David Lederer, Dr Thomas Bice

  31. Idiopathic Pulmonary Fibrosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2018, New England Journal of Medicine (NEJM/MMS)

    David Lederer

  32. Screening high-resolution computed tomography of the chest to detect interstitial lung disease in systemic sclerosis: a global survey of rheumatologists

    Article • Arthritis & Rheumatology, April 2018, Wiley

    David Lederer

  33. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant

    Article • American Review of Respiratory Disease, January 2018, American Thoracic Society

    David Lederer

  34. AnnalsATS 2022: Rigor, Value, Impact

    Article • Annals of the American Thoracic Society, December 2017, American Thoracic Society

    David Lederer

  35. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis)

    Article • American Review of Respiratory Disease, November 2017, American Thoracic Society

    David Lederer, Dr David J Lederer

  36. A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective

    Article • American Review of Respiratory Disease, November 2017, American Thoracic Society

    David Lederer

  37. Associations between emphysema-like lung on CT and incident airflow limitation: a general population-based cohort study

    Article • Thorax, October 2017, BMJ

    David Lederer

  38. Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies

    Article • American Review of Respiratory Disease, October 2017, American Thoracic Society

    David Lederer

  39. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension

    Article • Annals of the American Thoracic Society, October 2017, American Thoracic Society

    David Lederer

  40. A novel patient-centered “intention-to-treat” metric of U.S. lung transplant center performance

    Article • Arabian archaeology and epigraphy, September 2017, Wiley

    David Lederer

  41. Patient-centered Outcomes in Idiopathic Pulmonary Fibrosis Clinical Trials

    Article • American Review of Respiratory Disease, September 2017, American Thoracic Society

    David Lederer

  42. Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical Illness

    Article • Critical Care Medicine, June 2017, Wolters Kluwer Health

    David Lederer

  43. Genome-wide association study of subclinical interstitial lung disease in MESA

    Article • May 2017, Springer Science + Business Media

    David Lederer

  44. Antacid use and subclinical interstitial lung disease: the MESA study

    Article • European Respiratory Journal, May 2017, European Respiratory Society (ERS)

    Dr David J Lederer, David Lederer

  45. Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis

    Article • Annals of the American Thoracic Society, May 2017, American Thoracic Society

    Dr David J Lederer, David Lederer

  46. Diagnosing idiopathic pulmonary fibrosis without a lung biopsy: honeycombing not required

    Article • Thorax, March 2017, BMJ

    David Lederer

  47. The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness

    Article • Journal of the American Geriatrics Society, March 2017, Wiley

    David Lederer

  48. Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation

    Article • Arabian archaeology and epigraphy, February 2017, Wiley

    David Lederer

  49. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study

    Article • Thorax, January 2017, BMJ

    David Lederer

  50. Chest Fat Quantification via CT Based on Standardized Anatomy Space in Adult Lung Transplant Candidates

    Article • PLOS One, January 2017, PLOS

    David Lederer

  51. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

    Article • The Lancet Respiratory Medicine, January 2017, Elsevier

    David Lederer

  52. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

    Article • The Lancet Respiratory Medicine, January 2017, Elsevier

    David Lederer

  53. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction

    Article • Arabian archaeology and epigraphy, November 2016, Wiley

    David Lederer

  54. Primary graft dysfunction: Long-term physical function outcomes among lung transplant recipients

    Article • Heart & Lung, November 2016, Elsevier

    David Lederer

  55. The Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation

    Article • Annals of the American Thoracic Society, October 2016, American Thoracic Society

    David Lederer

  56. Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis

    Article • Thorax, September 2016, BMJ

    David Lederer

  57. Adipose Gene Expression Profile Changes With Lung Allograft Reperfusion

    Article • Arabian archaeology and epigraphy, August 2016, Wiley

    David Lederer

  58. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Article • American Review of Respiratory Disease, August 2016, American Thoracic Society

    David Lederer

  59. Novel Picture Guide for Spiritual Care in the ICU

    Article • Annals of the American Thoracic Society, August 2016, American Thoracic Society

    Dr. Matthew R Baldwin, David Lederer

  60. Frailty in Pulmonary and Critical Care Medicine

    Article • Annals of the American Thoracic Society, August 2016, American Thoracic Society

    David Lederer

  61. Polysomnographic Measurement of Sleep Duration and Bodily Pain Perception in the Sleep Heart Health Study

    Article • SLEEP, August 2016, Oxford University Press (OUP)

    David Lederer

  62. High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study

    Article • European Respiratory Journal, July 2016, European Respiratory Society (ERS)

    Dr David J Lederer, David Lederer

  63. Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

    Article • European Respiratory Journal, July 2016, European Respiratory Society (ERS)

    Dr Dominique Spirig, David Lederer, Carlo Albera

  64. Living with Interstitial Lung Disease: How Do We Best Meet the Educational Needs of Our Patients?

    Article • Annals of the American Thoracic Society, July 2016, American Thoracic Society

    David Lederer

  65. Donor lung assessment using selective pulmonary vein gases

    Article • European Journal of Cardio-Thoracic Surgery, May 2016, Oxford University Press (OUP)

    David Lederer

  66. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma

    Article • Journal of Asthma, April 2016, Taylor & Francis

    David Lederer

  67. Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of Atherosclerosis

    Article • PLOS One, April 2016, PLOS

    David Lederer

  68. Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study

    Article • Thorax, April 2016, BMJ

    David Lederer

  69. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia

    Article • The Journal of Heart and Lung Transplantation, April 2016, Elsevier

    David Lederer

  70. Fat quantification and analysis of lung transplant patients on unenhanced chest CT images based on standardized anatomic space

    Article • March 2016, SPIE

    David Lederer

  71. Fat segmentation on chest CT images via fuzzy models

    Article • March 2016, SPIE

    David Lederer

  72. Short stature and lung transplantation

    Article • American Review of Respiratory Disease, March 2016, American Thoracic Society

    Dr David J Lederer, David Lederer

  73. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

    Article • Thorax, March 2016, BMJ

    David Lederer

  74. Association of Forced Vital Capacity with the Developmental Gene NCOR2

    Article • PLOS One, February 2016, PLOS

    Andre FS Amaral, David Lederer

  75. Seeking and sharing: why the pulmonary fibrosis community engages the web 2.0 environment

    Article • BMC Pulmonary Medicine, January 2016, Springer Science + Business Media

    David Lederer

  76. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension

    Article • Annals of the American Thoracic Society, January 2016, American Thoracic Society

    Dr Stephen C Mathai, David Lederer

  77. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune RegulatorTOLLIPin Post-Lung Transplant Primary Graft Dysfunction Risk

    Article • Arabian archaeology and epigraphy, December 2015, Wiley

    David Lederer

  78. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

    Article • European Respiratory Journal, December 2015, European Respiratory Society (ERS)

    David Lederer

  79. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation

    Article • American Review of Respiratory Disease, December 2015, American Thoracic Society

    David Lederer

  80. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation

    Article • American Review of Respiratory Disease, November 2015, American Thoracic Society

    David Lederer

  81. A comparison of visual and quantitative methods to identify interstitial lung abnormalities

    Article • BMC Pulmonary Medicine, October 2015, Springer Science + Business Media

    David Lederer

  82. Editors' Introduction toAnnalsATSClinical Research Design Articles

    Article • Annals of the American Thoracic Society, October 2015, American Thoracic Society

    David Lederer, Dr John Hansen-Flaschen

  83. Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis

    Article • CHEST Journal, July 2015, Elsevier

    David Lederer

  84. Survival of Adults With Systemic Sclerosis Following Lung Transplantation: A Nationwide Cohort Study

    Article • Arthritis & Rheumatology, April 2015, Wiley

    David Lederer

  85. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation

    Article • Arabian archaeology and epigraphy, April 2015, Wiley

    David Lederer

  86. Interleukin-6 and Tumor Necrosis Factor-α Are Associated with Quality of Life–Related Symptoms in Pulmonary Arterial Hypertension

    Article • Annals of the American Thoracic Society, March 2015, American Thoracic Society

    David Lederer

  87. Neutrophil Extracellular Traps Are Pathogenic in Primary Graft Dysfunction after Lung Transplantation

    Article • American Review of Respiratory Disease, February 2015, American Thoracic Society

    David Lederer

  88. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

    Article • The Journal of Heart and Lung Transplantation, January 2015, Elsevier

    Christian Benden, David Lederer

  89. Association Between Emphysema-like Lung on Cardiac Computed Tomography and Mortality in Persons Without Airflow Obstruction

    Article • Annals of Internal Medicine, December 2014, American College of Physicians

    David Lederer

  90. Body Composition and Mortality after Adult Lung Transplantation in the United States

    Article • American Review of Respiratory Disease, November 2014, American Thoracic Society

    David Lederer

  91. Embracing Complex Diseases. The Case for an Idiopathic Pulmonary Fibrosis Biorepository

    Article • Annals of the American Thoracic Society, October 2014, American Thoracic Society

    David Lederer

  92. Intravenous Immunoglobulin for Hypogammaglobulinemia after Lung Transplantation: A Randomized Crossover Trial

    Article • PLOS One, August 2014, PLOS

    David Lederer

  93. Genome-wide association analysis identifies six new loci associated with forced vital capacity

    Article • Nature Genetics, June 2014, Nature

    Dr Stefan Enroth, David Lederer

  94. Plasma Complement Levels Are Associated with Primary Graft Dysfunction and Mortality after Lung Transplantation

    Article • American Review of Respiratory Disease, June 2014, American Thoracic Society

    David Lederer

  95. The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors

    Article • Journal of Critical Care, June 2014, Elsevier

    David Lederer

  96. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Anoop M Nambiar, David Lederer, Prof Dr Carlos R R Carvalho

  97. Interstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases

    Article • Annals of the American Thoracic Society, April 2014, American Thoracic Society

    David Lederer

  98. Genetic Variation in the Prostaglandin E2Pathway Is Associated with Primary Graft Dysfunction

    Article • American Review of Respiratory Disease, March 2014, American Thoracic Society

    David Lederer

  99. Preoperative Plasma Club (Clara) Cell Secretory Protein Levels Are Associated With Primary Graft Dysfunction After Lung Transplantation

    Article • Arabian archaeology and epigraphy, February 2014, Elsevier

    David Lederer

  100. Erratum

    Article • Arabian archaeology and epigraphy, January 2014, Wiley

    David Lederer

  101. Lung Transplantation and Atrial Septostomy in Pulmonary Arterial Hypertension

    Article • Clinics in Chest Medicine, December 2013, Elsevier

    David Lederer

  102. Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward

    Article • European Respiratory Journal, November 2013, European Respiratory Society (ERS)

    David Lederer

  103. High Burden of Palliative Needs among Older Intensive Care Unit Survivors Transferred to Post–Acute Care Facilities. A Single-Center Study

    Article • Annals of the American Thoracic Society, October 2013, American Thoracic Society

    David Lederer

  104. Pilot Study Exploring Lung Allograft Surfactant Protein A (SP-A) Expression in Association With Lung Transplant Outcome

    Article • Arabian archaeology and epigraphy, September 2013, Wiley

    David Lederer

  105. Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study

    Article • Arabian archaeology and epigraphy, August 2013, Wiley

    David Lederer

  106. Latent Class Analysis Identifies Distinct Phenotypes of Primary Graft Dysfunction After Lung Transplantation

    Article • CHEST Journal, August 2013, Elsevier

    David Lederer

  107. Donor Surfactant Protein D (SP-D) Polymorphisms Are Associated With Lung Transplant Outcome

    Article • Arabian archaeology and epigraphy, July 2013, Wiley

    David Lederer

  108. Gene Set Enrichment Analysis Identifies Key Innate Immune Pathways in Primary Graft Dysfunction After Lung Transplantation

    Article • Arabian archaeology and epigraphy, July 2013, Elsevier

    David Lederer

  109. Disparities in lung transplantation

    Article • The Journal of Heart and Lung Transplantation, July 2013, Elsevier

    David Lederer

  110. Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis

    Article • European Respiratory Journal, May 2013, European Respiratory Society (ERS)

    David Lederer

  111. Preoperative Serum Albumin Levels Predict 1-Year Postoperative Survival of Patients Undergoing Heart Transplantation

    Article • Circulation Heart Failure, May 2013, Wolters Kluwer Health

    David Lederer

  112. An Acute Change in Lung Allocation Score and Survival After Lung Transplantation

    Article • Annals of Internal Medicine, May 2013, American College of Physicians

    David Lederer

  113. A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness

    Article • CHEST Journal, April 2013, Elsevier

    David Lederer

  114. Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation

    Article • American Review of Respiratory Disease, March 2013, American Thoracic Society

    David Lederer

  115. Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation

    Article • PLOS One, December 2012, PLOS

    David Lederer

  116. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation

    Article • Translational Research, December 2012, Elsevier

    David Lederer

  117. Socioeconomic Barriers to Lung Transplantation

    Article • American Review of Respiratory Disease, November 2012, American Thoracic Society

    David Lederer

  118. Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation

    Article • American Review of Respiratory Disease, September 2012, American Thoracic Society

    David Lederer

  119. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation

    Article • The Journal of Heart and Lung Transplantation, September 2012, Elsevier

    David Lederer

  120. A comparison of single breath and re-breathe diffusing capacity in emphysema patients and controls

    Article • Respiratory Physiology & Neurobiology, July 2012, Elsevier

    David Lederer

  121. Postoperative Estradiol Levels Associate With Development of Primary Graft Dysfunction in Lung Transplantation Patients

    Article • Gender Medicine, June 2012, Elsevier

    David Lederer

  122. Is Obstructive Sleep Apnea a Cause of Idiopathic Pulmonary Fibrosis?

    Article • Archives of Pathology & Laboratory Medicine, May 2012, Archives of Pathology and Laboratory Medicine

    David Lederer

  123. Secondary Prevention of Idiopathic Pulmonary Fibrosis: Catching the Horse Still in the Barn

    Article • American Review of Respiratory Disease, April 2012, American Thoracic Society

    David Lederer

  124. Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, February 2012, Taylor & Francis

    David Lederer

  125. Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study

    Article • Arabian archaeology and epigraphy, February 2012, Wiley

    David Lederer

  126. Selecting lung transplant candidates: where do current guidelines fall short?

    Article • Expert Review of Respiratory Medicine, February 2012, Taylor & Francis

    David Lederer

  127. Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading

    Article • Circulation, January 2012, Wolters Kluwer Health

    Dr Barry A Borlaug, David Lederer

  128. Plasma Endothelin-1 and Vascular Endothelial Growth Factor Levels and Their Relationship to Hemodynamics in Idiopathic Pulmonary Fibrosis

    Article • Respiration, January 2012, Karger Publishers

    David Lederer

  129. Translational Research in Lung Transplantation: How Do We Get From Mouse to Human?

    Article • Arabian archaeology and epigraphy, December 2011, Wiley

    David Lederer

  130. Two, One, or None for Chronic Obstructive Pulmonary Disease: Who Decides and How?

    Article • American Review of Respiratory Disease, December 2011, American Thoracic Society

    David Lederer

  131. Obesity and Primary Graft Dysfunction after Lung Transplantation

    Article • American Review of Respiratory Disease, November 2011, American Thoracic Society

    David Lederer

  132. Delayed Access and Survival in Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, October 2011, American Thoracic Society

    David Lederer

  133. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis

    Article • European Respiratory Journal, September 2011, European Respiratory Society (ERS)

    David Lederer

  134. Elevated Plasma Long Pentraxin-3 Levels and Primary Graft Dysfunction After Lung Transplantation for Idiopathic Pulmonary Fibrosis

    Article • Arabian archaeology and epigraphy, August 2011, Wiley

    David Lederer

  135. Effect of Single vs Bilateral Lung Transplantation on Plasma Surfactant Protein D Levels in Idiopathic Pulmonary Fibrosis

    Article • CHEST Journal, August 2011, Elsevier

    David Lederer

  136. Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT

    Article • Circulation, May 2011, Wolters Kluwer Health

    David Lederer, Dr. Erika Berman Rosenzweig

  137. Lung Volume Reduction Surgery Using the NETT Selection Criteria

    Article • The Annals of Thoracic Surgery, May 2011, Elsevier

    David Lederer

  138. Elevated Pulmonary Artery Pressure Is a Risk Factor for Primary Graft Dysfunction Following Lung Transplantation for Idiopathic Pulmonary Fibrosis

    Article • CHEST Journal, April 2011, Elsevier

    David Lederer

  139. Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT

    Article • Contemporary Clinical Trials, March 2011, Elsevier

    David Lederer

  140. Elevated Plasma Clara Cell Secretory Protein Concentration Is Associated with High-Grade Primary Graft Dysfunction

    Article • Arabian archaeology and epigraphy, February 2011, Wiley

    David Lederer

  141. Micromechanics of Alveolar Edema

    Article • American Journal of Respiratory Cell and Molecular Biology, January 2011, American Thoracic Society

    David Lederer

  142. Construct validity of the definition of primary graft dysfunction after lung transplantation

    Article • The Journal of Heart and Lung Transplantation, November 2010, Elsevier

    David Lederer

  143. Vascular Inflammation in Obesity and Sleep Apnea

    Article • Circulation, February 2010, Wolters Kluwer Health

    David Lederer

  144. Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction

    Article • American Review of Respiratory Disease, November 2009, American Thoracic Society

    David Lederer

  145. Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation

    Article • American Review of Respiratory Disease, November 2009, American Thoracic Society

    David Lederer

  146. Cigarette Smoking Is Associated with Subclinical Parenchymal Lung Disease

    Article • American Review of Respiratory Disease, September 2009, American Thoracic Society

    David Lederer

  147. Soluble P-Selectin and the Risk of Primary Graft Dysfunction After Lung Transplantation

    Article • CHEST Journal, July 2009, Elsevier

    David Lederer

  148. Tacrolimus and Azathioprine Versus Cyclosporine and Mycophenolate Mofetil After Lung Transplantation: A Retrospective Cohort Study

    Article • The Journal of Heart and Lung Transplantation, July 2009, Elsevier

    David Lederer

  149. Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea

    Article • European Respiratory Journal, April 2009, European Respiratory Society (ERS)

    David Lederer

  150. Serum Albumin Concentration and Waiting List Mortality in Idiopathic Interstitial Pneumonia

    Article • CHEST Journal, April 2009, Elsevier

    David Lederer

  151. Quantification of single-breath underestimation of lung volume in emphysema

    Article • Respiratory Physiology & Neurobiology, February 2009, Elsevier

    David Lederer

  152. Platelets Enhance Endothelial Adhesiveness in High Tidal Volume Ventilation

    Article • American Journal of Respiratory Cell and Molecular Biology, November 2008, American Thoracic Society

    David Lederer

  153. The Modification of Diet in Renal Disease (MDRD) and the Prediction of Kidney Outcomes After Lung Transplantation

    Article • The Journal of Heart and Lung Transplantation, November 2008, Elsevier

    David Lederer

  154. Assessment of Kidney Function in Lung Transplant Candidates

    Article • The Journal of Heart and Lung Transplantation, June 2008, Elsevier

    David Lederer

  155. Use of an Interferon-γ Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients

    Article • CHEST Journal, April 2008, Elsevier

    David Lederer

  156. Platelet activation in the postoperative period after lung transplantation

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2008, Elsevier

    David Lederer

  157. Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, February 2008, American Thoracic Society

    David Lederer

  158. Plasma serotonin levels are normal in pulmonary arterial hypertension

    Article • Pulmonary Pharmacology & Therapeutics, February 2008, Elsevier

    David Lederer, Dr. Erika Berman Rosenzweig

  159. Outcomes after Lung Retransplantation in the Modern Era

    Article • American Review of Respiratory Disease, January 2008, American Thoracic Society

    David Lederer

  160. Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis

    Article • CHEST Journal, September 2007, Elsevier

    David Lederer

  161. Update in Surgical Therapy for Chronic Obstructive Pulmonary Disease

    Article • Clinics in Chest Medicine, September 2007, Elsevier

    David Lederer

  162. Risk Factors for Venous Thromboembolism After Lung Transplantation

    Article • CHEST Journal, August 2007, Elsevier

    David Lederer

  163. Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year

    Article • Journal of Thoracic and Cardiovascular Surgery, June 2007, Elsevier

    David Lederer

  164. Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis

    Article • Arabian archaeology and epigraphy, October 2006, Wiley

    David Lederer

  165. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension

    Article • Pulmonary Pharmacology & Therapeutics, October 2006, Elsevier

    David Lederer, Dr. Erika Berman Rosenzweig

  166. Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, September 2006, American Thoracic Society

    David Lederer

  167. Immunoglobulin G Levels before and after Lung Transplantation

    Article • American Review of Respiratory Disease, April 2006, American Thoracic Society

    David Lederer

  168. Racial and Ethnic Disparities in Survival in Lung Transplant Candidates with Idiopathic Pulmonary Fibrosis

    Article • Arabian archaeology and epigraphy, February 2006, Wiley

    David Lederer

  169. Osteoporosis in Diffuse Parenchymal Lung Disease

    Article • CHEST Journal, January 2006, Elsevier

    David Lederer

  170. Successful Bilateral Lung Transplantation for Pulmonary Fibrosis Associated With the Hermansky-Pudlak Syndrome

    Article • The Journal of Heart and Lung Transplantation, October 2005, Elsevier

    David Lederer

  171. Outcomes of Extended Donor Lung Recipients after Lung Transplantation

    Article • Transplantation, February 2005, Wolters Kluwer Health

    David Lederer